OrbiMed Capital GP III LLC, 10% Owner at PIERIS PHARMACEUTICALS, INC. (PIRS), sold 146,243 shares at $5.70 ($834K) on 2017-12-18, disclosed to the SEC on 2017-12-20.
Open-market sale of $834k PIRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VRAY | SELL | 2018-08-10 | $8.9M | — | Filing → |
| VRAY | SELL | 2018-08-10 | $4.8M | — | Filing → |
| VRAY | SELL | 2018-08-10 | $6.8M | — | Filing → |